JK
Jere Kurkipuro
View Jere's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
N/A
Sep 2022 - Present · 2 years and 4 months
Charles River Discovery
N/A
Sep 2016 - Sep 2017 · 1 years
N/A
Sep 2015 - Sep 2016 · 1 years
Company Details
11-50 Employees
Aurealis Therapeutics is a Swiss-Nordic Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapy platform, based on genetically modified safe lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammation. After successfully completing our Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients with our lead clinical product AUP-16, we are initiating our Phase 2 study in Italy, Germany and Poland, first for DFU. Venous Ulcers and Pressure Ulcers will follow. In Oncology, we are building on impressive pre-clinical data with Oncolytic Bacteria lead candidate AUP-55, which shows increased survival in Ovarian Cancer and peritoneal carcinomatosis. Our pipeline also includes Inflammation, at discovery stage.
Year Founded
2015
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
Microkatu 1 Kuopio, 70210, FI
Keywords
Cell and gene therapyRecombinant Live BiotherapeuticChronic woundsOncologyAdvanced Therapy Medicinal ProductInflammationand Oncolytic Bacteria
Discover More About Cleveland Clinic

Find verified contacts of Jere Kurkipuro in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.